Amanda Hartman is shopping for tighter clothes. Sarah Lowenthal has slashed her spending on junk food. Kait Handler snagged a pair of non-plus-size jeans that fit.
"I was never a shopper, probably because I couldn't be," said Handler, 40. "Those jeans were an indicator, a possibility, of what could be. They were a bellwether."
All three have changed their shopping habits after slimming down on glucagon-like peptide-1, or GLP-1, medications such as Ozempic, Wegovy and Zepbound. Industry experts expect many more Americans will do the same as those drugs’ explosive popularity, fueled by their ability to help people lose weight, reverberates across the retail sector.
Please select this link to read the complete article from The Washington Post.